Roche: top-selling drugs 2018-2019, by revenue

Roche is one of the top pharmaceutical companies globally. They have a variety of products and medications sold worldwide with oncology being a focus area of the company. As of 2019, Roche’s second top revenue generating drug was Herceptin (trastuzumab). Herceptin is a drug used in the treatment of some types of breast cancer. The drug generated about six billion Swiss francs in revenue during 2019.

Roche company overview

Roche is a multinational pharmaceutical company based in Basel, Switzerland. The company has two primary divisions: diagnostics and pharmaceuticals. Roche has experienced exceptional growth in recent years which can be seen in the increasing value of their sales globally. As well as sales, Roche has experienced significant growth in their research and development (R&D) expenditures. Roche has been named a leader in global pharma in several ways but has excelled in producing and selling oncologic pharmaceuticals specifically.

Oncology

Oncology is a branch of medicine that focuses on the diagnosis and treatment of cancer. The number of new cancer drugs under development in the United States is also increasing every year with significant growth recently. Oncologics and antidiabetics are the top two drug therapy areas in the United States based on drug spending.